Lucie B.M. Hijmering-Kappelle

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

Iris C. Kok, J.S. Hooiveld, Pim P. van de Donk et al. · Annals of Oncology · 2021 · 95 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non–Small-Cell Lung Cancer With Rare or Complex Mutational Profiles

Bart Koopman, Anthonie J. van der Wekken, Arja ter Elst et al. · JCO Precision Oncology · 2020 · 48 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Safety and Efficacy of Extended Interval Dosing for Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer During the COVID-19 Pandemic

Lucie B.M. Hijmering-Kappelle, T. Jeroen N. Hiltermann, Frederike Bensch · Clinical Lung Cancer · 2021 · 20 citations · Full text

Medicine, Oncology, Pharmacology +16

Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial

H. Kievit, M Benthe Muntinghe-Wagenaar, Lucie B.M. Hijmering-Kappelle et al. · Lung Cancer · 2023 · 14 citations · Full text

Medicine, Oncology, Radiation Oncology +17

The additional diagnostic value of virtual bronchoscopy navigation in patients with pulmonary nodules – The NAVIGATOR study

Birgitta I. Hiddinga, Dirk‐Jan Slebos, T. David Koster et al. · Lung Cancer · 2023 · 11 citations · Full text

Medicine, Clinical Sciences, Radiology +15